Semaglutide reconstitution is the process of dissolving lyophilised semaglutide powder with bacteriostatic water before laboratory use. The standard method is to add 1–2 mL of bacteriostatic water to the vial, swirl gently without shaking, and refrigerate the working solution protected from light. For a 5 mg vial in 2 mL of water, the resulting concentration […]
Monthly Archives: November 2026
Semaglutide is a long-acting GLP-1 receptor agonist studied in weight-management and metabolic research, with published trial doses ranging from 0.25 mg to 2.4 mg injected once weekly. In the STEP programme, the therapeutic maintenance dose was 2.4 mg per week after a stepwise titration from 0.25 mg. For laboratory research, protocols typically evaluate the same […]
Oxytocin acetate is the acetate salt of oxytocin, a cyclic nine-amino-acid neuropeptide with a disulfide-bridged ring, released from the posterior pituitary and acting centrally through oxytocin receptors (OXTR), GPCRs linked to phospholipase-C and calcium signaling. In the laboratory it supports OXTR pharmacology, receptor-expression assays, and model-system studies of social behavior and stress physiology; the human […]
The GHK-Cu 50 mg + KPV 10 mg blend is a two-component research formulation pairing GHK-Cu, the copper(II) complex of Gly-His-Lys, with KPV (Lys-Pro-Val), the C-terminal tripeptide of alpha-MSH. They sit at different points of the tissue-response loop: GHK-Cu has been studied for matrix remodeling, migration, and copper-associated signaling, while KPV appears in cellular and […]
What Is AOD9604? AOD9604 is a 16-amino-acid synthetic peptide corresponding to the C-terminal lipolytic region of human growth hormone (Tyr–hGH177–191), developed to isolate the fat-mobilizing activity associated with hGH while excluding the receptor-mediated growth and metabolic side effects of the full hormone; in preclinical metabolic studies it was reported to increase adipose lipolytic activity without […]
Human chorionic gonadotropin (hCG) is a heterodimeric glycoprotein hormone of approximately 37 kilodaltons, composed of a 92-amino-acid common alpha-subunit shared with LH, FSH, and TSH, and a distinct 145-amino-acid beta-subunit that confers receptor specificity. It activates the luteinizing hormone/choriogonadotropin receptor (LHCGR), a G-protein-coupled receptor, and its biological activity is standardized in International Units (IU), a […]
Tesamorelin is a synthetic GHRH (growth hormone-releasing factor) analog built on the 44-amino-acid sequence of human GRF, with a hexenoyl (C6, double bond at position 3) modification attached to the N-terminal tyrosine; the free-base molecular weight is 5,135.9 Da and the commercial pharmaceutical form (EGRIFTA) was first U.S.-approved in 2010. It binds and stimulates pituitary […]
GHK-Cu is the copper(II) complex of the naturally occurring tripeptide Gly-His-Lys (GHK), identified in human plasma in the 1970s and studied across extracellular-matrix remodeling, cell migration, angiogenesis, and copper-dependent enzyme biology. GHK binds Cu(II) with high affinity and acts both as peptide signal and copper transport chelate; gene-expression work links it to collagen, elastin, glycosaminoglycan, […]
LL-37 is the 37-amino-acid C-terminal peptide released from human cathelicidin precursor hCAP18 (CAMP), the sole cathelicidin family member identified in humans. It is a cationic, amphipathic alpha-helical peptide with two research faces: direct membrane-active antimicrobial activity against bacteria, fungi, and some enveloped viruses, plus receptor-mediated signaling linked to formyl peptide receptor 2 (FPR2) and other […]
What Is Cartalax? Cartalax is a synthetic ultrashort tripeptide with the reported sequence Ala–Glu–Asp (alanine–glutamic acid–aspartic acid; AED), developed within the peptide-bioregulator research program associated with Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology; it is hypothesized to modulate gene-expression programs relevant to chondrocytes and cartilage extracellular matrix. Unlike systemic signaling peptides, […]
